Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01606579
Title Safety and Efficacy Study of PRI-724 in Subjects With Advanced Myeloid Malignancies
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Prism Pharma Co., Ltd.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Emory University / Winship Cancer Institute Atlanta Georgia 30322 United States Details
University of Massachusetts Medical Center Worcester Massachusetts 01655 United States Details
New Mexico Cancer Care Alliance Albuquerque New Mexico 87106 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Ohio State University Columbus Ohio 43210-1267 United States Details
University of Texas M.D. Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field